Pre-made benchmark antibody with INN name
Virus-like particles (VLP) Platforms for immunogens, vaccines and drug carriers
Antibody-drug Conjugate (ADC): Pre-made ADC benchmark, MOA, Production and QC
Neutralizing antibodies of virus (SARS2, HIV, HBV, Rabies, RSV, Ebola, Influenza)
Immunoglobulin Fc receptors for Fc&Fc Receptor binding assay
ILIBRA-HuEasy Monoclonal antibody (mab) humanization service (fully humanized ab)
Single domain antibody (Nanobody)
SOCAIL MEDIA
GeneMedi provides pre-made research class therapeutic antibodies & Fusion Protein with WHO-INN name. The INN named antibodies & Fusion Protein are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody or Fusion Protein for cell culture, in vitro/in vivo assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Link to IMGT(Immunogenetics Information System)
Know more about INN named antibodies
Download about 
INN information from WHO
Product list
Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Order |
|---|---|---|---|---|---|---|
Pre-Made Domagrozumab biosimilar, Whole mAb, Anti-MSTN/GDF-8 Antibody: Anti-GDF8/MSLHP therapeutic antibody |
Domagrozumab |
NA |
MSTN |
Whole mAb |
||
Pre-Made Domvanalimab biosimilar, Whole mAb, Anti-TIGIT Antibody: Anti-VSIG9/VSTM3/WUCAM therapeutic antibody |
Domvanalimab |
NA |
TIGIT |
Whole mAb |
||
Pre-Made Donanemab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody |
Donanemab |
NA |
APP |
Whole mAb |
||
Pre-Made Dostarlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Dostarlimab |
NA |
PDCD1 |
Whole mAb |
||
Pre-Made Dovanvetmab biosimilar, Feline Whole Mab: Anti-IL31 (Feline) therapeutic antibody |
Dovanvetmab |
NA |
IL31 |
Feline Whole mAb |
||
Pre-Made Drozitumab biosimilar, Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody: Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5 therapeutic antibody |
Drozitumab |
NA |
TNFRSF10B |
Whole mAb |
||
Pre-Made Duligotuzumab biosimilar, Whole mAb, Anti-ERBB3/Erbb-3 Antibody: Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody |
Duligotuzumab |
duligotumab |
ERBB3 |
Whole mAb |
||
Pre-Made Dupilumab biosimilar, Whole mAb, Anti-IL4R Antibody: Anti-CD124 therapeutic antibody |
Dupilumab |
NA |
IL4R |
Whole mAb |
||
Pre-Made Durvalumab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody |
Durvalumab |
NA |
CD274 |
Whole mAb |
||
Pre-Made Dusigitumab biosimilar, Whole mAb, Anti-IGF1;IGF2 Antibody: Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3 therapeutic antibody |
Dusigitumab |
NA |
IGF1&IGF2 |
Whole mAb |
||
Pre-Made Duvortuxizumab biosimilar, Bispecific scFv with Crossover, Anti-CD19;CD3E antibody: Anti-B4/CVID3;T3E/TCRE/IMD18 therapeutic antibody |
Duvortuxizumab |
NA |
CD19,CD3E |
Bispecific scFv with Crossover |
||
Pre-Made Ebdarokimab biosimilar, Whole mAb, Anti-IL12B Antibody: Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2 therapeutic antibody |
Ebdarokimab |
NA |
IL12B |
Whole mAb |
||
Pre-Made Ebronucimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody |
Ebronucimab |
NA |
PCSK9 |
Whole mAb |
||
Pre-Made Eculizumab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody |
Eculizumab |
NA |
C5 |
Whole mAb |
||
Pre-Made Edrecolomab biosimilar, Whole mAb, Anti-EPCAM Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody |
Edrecolomab |
NA |
EPCAM |
Whole mAb |
||
Pre-Made Efalizumab biosimilar, Whole mAb, Anti-ITGAL Antibody: Anti-CD11A/LFA-1/LFA1A therapeutic antibody |
Efalizumab |
NA |
ITGAL |
Whole mAb |
||
Pre-Made Efungumab biosimilar, scFv: Anti-Heat Shock Protein 90 Homolog therapeutic antibody |
Efungumab |
NA |
Heat Shock Protein 90 Homolog |
scFv |
||
Pre-Made Eldelumab biosimilar, Whole mAb, Anti-CXCL10 Antibody: Anti-C7/IFI10/INP10/IP-10/SCYB10/crg-2/gIP-10/mob-1 therapeutic antibody |
Eldelumab |
NA |
CXCL10 |
Whole mAb |
||
Pre-Made Elezanumab biosimilar, Whole mAb, Anti-RGMA Antibody: Anti-RGM therapeutic antibody |
Elezanumab |
NA |
RGMA |
Whole mAb |
||
Pre-Made Elgemtumab biosimilar, Whole mAb, Anti-ERBB3/Erbb-3 Antibody: Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody |
Elgemtumab |
NA |
ERBB3 |
Whole mAb |
||
Pre-Made Elipovimab biosimilar, Whole Mab: Anti-HIV-1 gp120 therapeutic antibody |
Elipovimab |
NA |
HIV-1 gp120 |
Whole mAb |
||
Pre-Made Elotuzumab biosimilar, Whole mAb, Anti-SLAMF7/CS1 Antibody: Anti-19A/CD319/CRACC therapeutic antibody |
Elotuzumab |
NA |
SLAMF7 |
Whole mAb |
||
Pre-Made Eluvixtamab biosimilar, Bispecific scFv, Anti-CD33;CD3E Antibody: Anti-p67/SIGLEC3/SIGLEC-3;T3E/TCRE/IMD18 therapeutic antibody |
Eluvixtamab |
NA |
CD33,CD3E |
Bispecific scFv |
||
Pre-Made Emactuzumab biosimilar, Whole mAb, Anti-CSF1R Antibody: Anti-FMS/CSFR/FIM2/HDLS/C-FMS/CD115/HDLS1/CSF-1R/BANDDOS/M-CSF-R therapeutic antibody |
Emactuzumab |
NA |
CSF1R |
Whole mAb |
||
Pre-Made Emapalumab biosimilar, Whole mAb, Anti-IFNG Antibody: Anti-IFG/IFI/IMD69 therapeutic antibody |
Emapalumab |
NA |
IFNG |
Whole mAb |
||
Pre-Made Emerfetamab biosimilar, Bispecific scFv, Anti-CD33;CD3E Antibody: Anti-p67/SIGLEC3/SIGLEC-3;T3E/TCRE/IMD18 therapeutic antibody |
Emerfetamab |
NA |
CD33,CD3E |
Bispecific scFv |
||
Pre-Made Emicizumab biosimilar, Bispecific mAb, Anti-F9;F10 Antibody: Anti-FIX/HEMB/P19/PTC/THPH8;FX/FXA therapeutic antibody |
Emicizumab |
NA |
F9,F10 |
Bispecific mAb |
||
Pre-Made Emibetuzumab biosimilar, Whole mAb, Anti-MET Antibody: Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody |
Emibetuzumab |
NA |
MET |
Whole mAb |
||
Pre-Made Enapotamab biosimilar, Whole mAb ADC, Anti-AXL Antibody: Anti-ARK/UFO/JTK11/Tyro7 therapeutic antibody |
Enapotamab |
NA |
AXL |
Whole mAb ADC |
||
Pre-Made Enavatuzumab biosimilar, Whole mAb, Anti-TNFRSF12A Antibody: Anti-CD2664/TWEAKR therapeutic antibody |
Enavatuzumab |
NA |
TNFRSF12A |
Whole mAb |
||
Pre-Made Encelimab biosimilar, Whole mAb, Anti-LAG3 Antibody: Anti-CD223 therapeutic antibody |
Encelimab |
NA |
LAG3 |
Whole mAb |
||
Pre-Made Enfortumab biosimilar, Whole mAb ADC, Anti-PVRL4/NECTIN4 Antibody: Anti-EDSS1/LNIR/PRR4/nectin-4 therapeutic antibody |
Enfortumab |
NA |
PVRL4 |
Whole mAb ADC |
||
Pre-Made Enibarcimab biosimilar, Whole mAb, Anti-ADM Antibody: Anti-AM/PAMP therapeutic antibody |
Enibarcimab |
NA |
ADM |
Whole mAb |
||
Pre-Made Enoblituzumab biosimilar, Whole mAb, Anti-CD276 Antibody: Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic antibody |
Enoblituzumab |
NA |
CD276 |
Whole mAb |
||
Pre-Made Enokizumab biosimilar, Whole mAb, Anti-IL9 Antibody: Anti-HP40/IL-9/P40 therapeutic antibody |
Enokizumab |
NA |
IL9 |
Whole mAb |
||
Pre-Made Enoticumab biosimilar, Whole mAb, Anti-DLL4 Antibody: Anti-AOS6/delta4/hdelta2 therapeutic antibody |
Enoticumab |
NA |
DLL4 |
Whole mAb |
||
Pre-Made Ensituximab biosimilar, Whole mAb, Anti-MUC5AC Antibody: Anti-MUC5/TBM/leBin therapeutic antibody |
Ensituximab |
NA |
MUC5AC |
Whole mAb |
||
Pre-Made Envafolimab biosimilar, Single Domain Variable Fragment;H, Anti-CD274/PD-L1 Antibody: Anti-B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1, hPD-L1 therapeutic antibody |
Envafolimab |
NA |
PDL1 |
Single Domain Variable Fragment;H |
||
Pre-Made Envafolimab biosimilar, Single Domain Variable Fragment;H, Anti-CD274/PD-L1 Antibody: Anti-B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1, hPD-L1 therapeutic antibody |
Epcoritamab |
NA |
CD3E,MS4A1 |
Bispecific mAb |
||
Pre-Made Epratuzumab biosimilar, Whole mAb, Anti-CD22 Antibody: Anti-SIGLEC2/SIGLEC-2 therapeutic antibody |
Epratuzumab |
NA |
CD22 |
Whole mAb |
||
Pre-Made Eptinezumab biosimilar, Whole mAb, Anti-CALCA;CALCB Antibody: Anti-CT/KC/PCT/CGRP/CALC1/CGRP1/CGRP-I/CGRP-alpha;CALC2/CGRP-II/CGRP2 therapeutic antibody |
Eptinezumab |
NA |
CALCA&CALCB |
Whole mAb |
||
Pre-Made Eramkafusp biosimilar, Whole mAb Fusion, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Eramkafusp |
NA |
CD20 |
Whole mAb Fusion |
||
Pre-Made Erenumab biosimilar, Whole mAb, Anti-CALCRL/CGRPR Antibody: Anti-CRLR/LMPHM8 therapeutic antibody |
Erenumab |
NA |
CALCRL |
Whole mAb |
||
Pre-Made Erfonrilimab biosimilar, Bispecific Single Domains (VH-VH'-CH), Anti-CD274/PD-L1;CTLA4/CTLA-4 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic ant |
Erfonrilimab |
NA |
CD274,CTLA4 |
Bispecific Single Domains (VH-VH'-CH) |
||
Pre-Made Etaracizumab biosimilar, Whole mAb, Anti-ITGAV;ITGB3 Antibody: Anti-CD51/MSK8/VNRA/VTNR;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2 therapeutic antibody |
Etaracizumab |
NA |
ITGAV_ITGB3 |
Whole mAb |
||
Pre-Made Etesevimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Etesevimab |
NA |
SARS-CoV-2 Spike RBD |
Whole mAb |
||
Pre-Made Etevritamab biosimilar, Bispecific scFv, Anti-EGFR;CD3E Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;T3E/TCRE/IMD18 therapeutic antibody |
Etevritamab |
NA |
EGFR,CD3E |
Bispecific scFv |
||
Pre-Made Etigilimab biosimilar, Whole mAb, Anti-TIGIT Antibody: Anti-VSIG9/VSTM3/WUCAM therapeutic antibody |
Etigilimab |
NA |
TIGIT |
Whole mAb |
||
Pre-Made Etokimab biosimilar, Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody |
Etokimab |
NA |
IL13 |
Whole mAb |
||
Pre-Made Etrolizumab biosimilar, Whole Mab: Anti-ITGA4;ITGB7;ITGAE;ITGB7 therapeutic antibody |
Etrolizumab |
NA |
ITGA4_ITGB7&ITGAE_ITGB7 |
Whole mAb |
